ASIS Corporation Report issue

For profit Phase 2
Founded: Westminster CA United States (2006)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2016
NCT02074163
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

li nguyen

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dystonia (Phase 2)

Dystonic Disorders (Phase 2)

Immunologic Deficiency Syndromes (Phase 2)

Migraine Disorders (Phase 2)

Muscle Hypertonia (Phase 2)

Muscle Spasticity (Phase 2)

Neck Pain (Phase 2)

Psoriasis (Phase 2)

Torticollis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 4